Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)
Clinical trial NCT04545112 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04545112
- Sponsor
- Xeltis
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2027-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.